The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma

INTRODUCTION: For patients with diffuse large B‐cell lymphoma (DLBCL), standard‐care is rituximab administered with CHOP or CHOP‐like chemotherapy (R‐CHOP). However, the effectiveness and safety of R‐CHOP among DLBCL patients with human immunodeficiency virus (HIV) infection is less clear, as HIV+ p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Habbous, Steven, Guo, Helen, Beca, Jaclyn, Dai, Wei Fang, Isaranuwatchai, Wanrudee, Cheung, Matthew, Chan, Kelvin K. W.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541135/
https://ncbi.nlm.nih.gov/pubmed/32794362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3362
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky